What Happens When a Pet Supplement Is Marketed Like a Drug?

Written by a licensed veterinarian and medical advisor to pet brands. All guidance reflects current veterinary standards and marketing compliance considerations.

Pet supplement marketing is one of the trickiest lanes in the pet industry. The brand wants compelling copy. The marketing team wants conversion. The product team wants to communicate benefits clearly. The veterinarian wants accuracy. The regulatory team wants fewer problems.

And somewhere in the middle, one phrase can quietly shift a product from “wellness support” into “this sounds like an unapproved animal drug.”

😬

When a pet supplement is marketed as if it can diagnose, treat, mitigate, cure, or prevent disease, the brand may create risk with FDA-CVM, FTC, NAD, state feed regulators, retailers, platforms, and veterinary partners. FDA states that unapproved animal drugs are new animal drugs without legal marketing status and that it is illegal to market unapproved new animal drugs without appropriate FDA review and legal status. That matters for pet supplement brands because when supplement marketing suggests a product is intended to treat, prevent, cure, mitigate, or manage disease, the product can begin to look less like a wellness supplement and more like an unapproved animal drug in the eyes of regulators.

This is why pet supplement claims need more than creativity. They need veterinary, scientific, and regulatory-aligned review before they reach the public. This blog posts explores all the regulatory lanes that pet supplement claims need to successful navigate to stay credible and compliant.

Need help translating supplement benefits into compliant, credible marketing language? That is exactly what a veterinary claims review is designed to do.

Read More